Background Although pneumoperitoneum has been suspected as a possible cause of transient elevation of liver function tests (LFTs) after laparoscopic surgery, liver damage by direct retraction could also influence postoperative LFTs. The aim of this study was to clarify whether laparoscopic gastrectomy (LG) using a Nathanson retractor was associated with the postoperative elevation of LFTs compared with open gastrectomy (OG). Methods A retrospective cohort study of 199 LG and 120 OG patients was conducted. Serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), and total bilirubin were measured before operation and at postoperative days 1, 3, and 7. Abnormal elevation of LFTs was defined as a grade 2 or greater elevation in any parameter. To assess the possible effect of pneumoperitoneum, patients who underwent laparoscopic (n = 324) and open (n = 56) colectomy for colorectal cancer were also compared. Results In both LG and OG groups, LFTs were significantly elevated postoperatively compared with baseline values. Mean ALT and total bilirubin levels on days 1, 3, and 7 were significantly higher in the LG than OG group. Abnormal elevation of LFTs was more frequent in the LG than OG group (50 vs. 12%). In multivariate analysis, LG was significantly associated with postoperative liver dysfunction (odds ratio [OR] = 7.99; 95% confidence interval [95% CI] = 3.69-18.85). No significant difference in the elevation of the LFTs was observed between laparoscopic and open colectomy (6% and 9%, respectively). Conclusions LG resulted in frequent elevation of LFTs. Care should be taken to minimize intraoperative liver damage when performing LG using a Nathanson retractor.
Introduction
To pursue minimally invasive surgery for gastric cancer, laparoscopic gastrectomy (LG) was developed and has been increasingly applied in recent years. Several case series studies reported the safety and clinical benefits of LG, including early postoperative recovery and better cosmetic results [1] [2] [3] . A recent phase II feasibility study of LG in Japanese patients has reported a low frequency (9.1%) of overall surgical complications, confirming its safety when performed by experienced surgeons [4] .
Although overall surgical morbidity does not seem to increase with LG, some studies have shown transient elevation of liver function tests (LFTs) in a substantial proportion of patients after LG [5] [6] [7] . Similar transient alterations in LFTs have been reported in other types of laparoscopic surgery such as cholecystectomy, colectomy, gastric bypass, and Nissen fundoplication [5, [8] [9] [10] [11] [12] [13] . Some studies suggest that the increase in intra-abdominal pressure by pneumoperitoneum impairs hepatic venous outlet and causes transient liver damage [5] [6] [7] .
Other possible causes of postoperative liver dysfunction in laparoscopic surgery include patient position, anesthetic agents, division of aberrant left hepatic artery (ALHA), and direct liver manipulation [5, 6, [10] [11] [12] [14] [15] [16] . Among these factors, liver manipulation should have a greater impact in LG because it is critical to retract the overhanging hepatic lateral lobe for lymph node dissection. We have introduced the use of a Nathanson liver retractor in LG to maintain a good operative field. Although some studies of antireflux or bariatric surgery have suggested that this method could cause postoperative liver dysfunction [12] , the effect of the routine use of the Nathanson liver retractor in LG on postoperative LFTs has not been investigated.
The aim of this study was to clarify whether performing LG using a Nathanson retractor was associated with postoperative elevation of LFTs compared with open gastrectomy (OG) under appropriate adjustment for imbalance of the patients' clinicopathological characteristics and potential confounders. In addition, to evaluate the possible effect of pneumoperitoneum on transient liver dysfunction, the proportion and the extent of liver enzyme elevations between laparoscopic colectomy (LC) and open colectomy (OC) patients were compared.
Materials and methods

Patients
This study was approved by the ethics committee of Kyoto University. The records of all 373 consecutive patients with histologically proven primary gastric cancer who underwent total or distal gastrectomy in our institution between July 2005 and March 2010 were reviewed. To regulate imbalances in patients' preoperative liver function, the following patients were excluded: (1) those with liver metastasis or primary liver tumors; (2) those with chronic hepatic disease such as HBs antigen positive, hepatitis C virus positive, autoimmune liver disease, and alcoholic hepatitis; and (3) those with grade 2 or greater abnormal increase of aspartate aminotransferase (AST), alanine aminotransferase (ALT), and/or total bilirubin on preoperative laboratory tests as classified according to the National Cancer Institute Common Terminology Criteria for Adverse Events (NCI-CTCAE) version 4.0. As a result, 319 patients were included for analysis. Among them, 199 patients underwent LG (LG group) and 120 patients underwent OG (OG group). To examine the sole effect of pneumoperitoneum on transient liver dysfunction, all 560 consecutive patients with histologically proven primary colorectal cancer who underwent colectomy in our institution during the same period were also reviewed. After exclusion of patients according to the same criteria, the laparoscopic colectomy (LC) and open colectomy (OC) groups comprised 324 and 56 patients, respectively. Patients who required conversion from laparoscopic to open surgery were assigned to the LC group according to the intention-to-treat principle.
Surgical procedure
The procedure for LG was previously described in detail [17, 18] . Briefly, the patient was placed in a modified lithotomy position. After the first port was inserted through the umbilicus and CO 2 pneumoperitoneum at 8 mmHg was established, four operating ports were placed. A Nathanson liver retractor (Cook Japan, Tokyo, Japan) was inserted and fixed with a retractor holder in an appropriate fashion. During the procedure the patient was placed in the reverse Trendelenburg position. Lymph node dissection was carried out with the use of ultrasonically activated coagulating shears (SonoSurg Ò ; Olympus, Tokyo, Japan), and the stomach was resected using endoscopic linear staplers. Intracorporeal reconstruction was then carried out with either the Billroth-I or Roux-en-Y method [14, 19] .
OG was performed through an upper transverse laparotomy incision. Lymph node dissection was performed using monopolar and bipolar electric cautery. A blade-type liver retractor for open surgery was routinely used with a retractor holder when performing dissection of suprapyloric or subcardial lymph nodes. Reconstruction was performed with a Roux-en-Y method in both distal and total gastrectomy. Radical lymphadenectomy, which was defined as D2 or ''modified D2'' lymph node dissection, was performed in both groups. D2 was defined according to the general rules of the Japanese Association of Gastric Cancer (13th ed.) [20] , whereas lymph node stations #12a and/or #14v were not dissected in ''modified D2.'' In all cases, prophylactic antibiotics were administered prior to and every 3 h during the operation.
tumor staging was based on physical examination, radiologic examination (computed tomography and/or magnetic resonance imaging), upper gastrointestinal series, ultrasonography, and endoscopy. Before April 2009, LG was used only for patients with a tumor depth limited to T3 (SS) and without lymph node metastases. After that period, indication for LG was extended to patients with more advanced diseases.
Data extraction and blood samples
Data of baseline clinical characteristics, operative parameters, postoperative complications, and pathological reports were extracted from the prospectively maintained database of patients who underwent gastrectomy in our department. Laboratory data were collected from medical charts. Blood samples were obtained before surgery and on postoperative days 1, 3, and 7 to measure serum AST, ALT, and total bilirubin levels. Total bilirubin and AST and ALT activities were measured with an automatic analyzer (TBA-200FR, Toshiba, Tokyo, Japan; and Dimension, Dade Behring, Germany).
Outcomes
The main study outcome was the proportion of ''abnormal elevation of LFTs.'' The liver function parameters (AST, ALT, and total bilirubin) at each time point were classified according to the NCI-CTCAE grading system (version 4.0). ''Abnormal elevation'' was defined as a grade 2 or greater increase in LFTs at any time point compared to the baseline. In the CTCAE, a grade 2 increase of AST and ALT was defined as [3.0-5.0 9 upper limit of normal (ULN), and a grade 2 increase of total bilirubin was defined as [1.5-3.0 9 ULN. In our institution, the ULNs of AST and total bilirubin were 33 IU/l and 1.3 mg/dl, respectively. The ULN of ALT was 42 IU/l for males and 27 IU/l for females.
Postoperative adverse events such as pneumonia, pleural effusion, atelectasis, cardiac events (myocardial infarction, heart failure, arrhythmia), anastomotic leakage, anastomotic stenosis, ileus, diarrhea, and wound infection were classified according to the NCI-CTCAE. Postoperative complications were defined as grade 2 or greater adverse events that occurred within 30 days of the operation. The pathological classification of the primary tumor, the degree of lymph node involvement, and the presence of organ metastasis were defined according to the TNM classification (version 7), and R classification was used to describe the extent of residual disease after gastrectomy (R0, no residual tumor; R1, microscopic residual tumor; R2, macroscopic residual tumor) [21] . Thirty-day mortality was defined as death within 30 days of the operation.
Statistical analysis
Continuous variables are presented as means (±SD) and were compared using Student's t-test. Categorical data were compared with the v 2 test. Logistic regression models were used to compare the occurrence of abnormal elevation of LFTs between the LG and OG groups. Bivariate and multivariate analyses were performed for independent variables. Variables with a p value \0.20 in the bivariate analysis were included in the multivariate analysis. In the multivariate analysis, a p value \0.05 was considered statistically significant. All statistical analyses were performed using JMP version 8.0.2 software (SAS Institute, Cary, NC).
Results
Patient characteristics and surgical outcomes
The clinical and pathologic characteristics of the 319 eligible gastric cancer patients are given in Table 1 . There was no significant difference in age, gender, body mass index, alcohol use, and medical history between the LG and OG groups. More patients in the OG group received neoadjuvant chemotherapy (25% vs. 7%) and underwent total gastrectomy (50% vs. 32%) than in the LG group. The mean preoperative serum albumin in the LG group was higher than that in the OG group. Reflecting the difference of operative indication, the LG group included fewer patients with advanced-stage lymph node metastasis or T3/4 tumors compared with the OG group.
Surgical outcomes are given in Table 2. LG was performed with significantly less blood loss compared to OG (80 vs. 472 g, p \ 0.001), while the operating time for LG was longer than that for OG (301 vs. 271 min, p = 0.049). In addition, hospital stay was significantly shorter in the LG group. There was a higher proportion of LG patients with an earlier stage; R0 was achieved in 96% of these patients, while 25% of the OG patients resulted in R1/2 resection. There were significantly fewer overall complications in the LG group (18 patients; 9%) than in the OG group (22 patients; 18%) (p = 0.015). Liver infarction was diagnosed by computed tomography in one LG patient (Fig. 1) ; spiking fever in this patient subsided with antibiotics treatment within a week. One patient in each group underwent reoperation due to anastomotic leakage, and one patient who underwent laparoscopic total gastrectomy had reoperation due to ischemic perforation of the ileum. The patient was a 77-year-old woman with diabetes mellitus and hypertension, and pathological examination revealed the segmental ischemia of ileum due to thromboembolic occlusion of the mesenteric artery. Because we did not manipulate the ileum during LG, the complication was not directly related to the intraoperative procedure.
Details of the clinical and pathological features of 380 colorectal cancer patients are given in Table 3 . There were no significant differences in age, gender, body mass index, tumor site, or operation time between the LC and OC groups. Mean blood loss in the LC group was significantly less than that in the OC group (33 vs. 430 g, p \ 0.001). In addition, the LC group included more patients with an earlier pathological tumor stage.
Comparison of abnormal elevation of LFTs between LG and OG
The laboratory data of the LFTs are listed in Table 4 and shown in Fig. 2 . In both LG and OG groups, AST and ALT levels were significantly elevated after the operation compared with the baseline values and reached peaks on the first postoperative day. AST levels decreased more rapidly than ALT levels in both groups and returned to baseline at day 7. No increase in either the AST or ALT level was observed in the LC or OC group. Total bilirubin levels were significantly elevated compared to the baseline values in all groups and gradually decreased to baseline at day 7.
In comparison between the LG and OG groups, mean AST levels on postoperative days 1 and 3 and mean ALT and total bilirubin levels on days 1, 3, and 7, were significantly higher in the LG group (p \ 0.001), indicating the delayed recovery of ALT and total bilirubin levels in these patients.
Abnormal elevation of LFTs, which was defined as a grade 2 or greater elevation in either parameter, was observed in 99 of the 199 LG patients (50%). On the other hand, only 14 of the 120 OG patients (12%) showed an increased level of LFTs. There was no significant difference in the proportion of altered LFTs between the LC and OC groups (6% and 9%, respectively).
Bivariate and multivariate analyses for the abnormal elevation of LFTs
Bivariate and multivariate logistic regression analyses regarding the proportion of abnormal elevation of LFTs were performed for all 319 patients who underwent gastrectomy (Table 5 ). In the bivariate analysis, LG, serum albumin, cholecystectomy, and operating time were significant risk factors related to abnormal LFTs. In the multivariate model that included variables with a p value \0.20 in the bivariate analysis, LG was the only independent risk factor for abnormal elevation of LFTs (adjusted OR = 7.99; 95% CI = 3.69-18.85; p \ 0.001). Age, gender, body mass index, preoperative serum albumin, cholecystectomy, depth of tumor invasion, and lymph node metastasis were not associated with abnormal LFTs.
Postoperative course of patients with elevated LFTs
Postoperative course of patients with abnormally elevated LFTs after LG (n = 99) was compared with that of LG patients without elevated LFTs (n = 100). There was no significant difference in postoperative complications (10% vs. 8%, p = 0.605). Mean postoperative hospital stay was also similar between the two groups (16 vs. 14 days, p = 0.154).
Discussion
Our study showed that there was a significantly higher proportion of abnormal elevation of LFTs in the LG group than the OG group. Notably, nearly half of the LG patients Death within 30 days 0 0 Fig. 1 Liver infarction following laparoscopic gastrectomy. Contrast-enhanced computed tomography revealed a wedge-shaped lowattenuation area in the lateral segment on the fourth postoperative day experienced more than three times elevation of liver enzymes postoperatively. Because this is an observational study, careful analysis and interpretation of results is necessary. First, in consideration of confounding factors, we excluded cases of liver tumor or liver disease to reduce the factors affecting postoperative liver function. Second, selection bias between the two groups should be considered. Because LG was used only in patients with a tumor depth of T3 (SS) in the earlier period of this study, tumor stage or metastatic status was not matched between the LG and OG groups. To control for such imbalance, a logistic regression model was adopted. Even after adjustment for these potential confounders, LG remained the only factor responsible for abnormal elevation of LFTs. In previous studies, factors such as anesthetic agents, patient position, direct liver manipulation, division of an aberrant left hepatic artery (ALHA), and pneumoperitoneum have been reported as possible causes for transient liver enzyme elevation after laparoscopic surgery [5, 6, 10-12, 15, 16] . Among these factors, anesthetic agents were the same in both groups in our study. Pneumoperitoneum has been argued to be the main cause of postoperative hepatic dysfunction in several studies regarding laparoscopic surgery [5, [8] [9] [10] [11] [12] [13] . A decreased blood flow in the liver due to the pressure of pneumoperitoneum has been suggested as the possible mechanism. However, a study using transesophageal echocardiography has demonstrated an opposite effect of pneumoperitoneum-an elevated hepatic flow during laparoscopic procedures [22] . Moreover, in a large case series study of more than 1,000 laparoscopic cholecystectomies, postoperative LFT was elevated in only 3.9% of patients [8] . In our study, to exclude the effect of liver manipulation and to investigate the sole effect of pneumoperitoneum on LFTs, patients who underwent LC were examined. Abnormal elevation of LFTs was observed in only 6% of the LC patients, which is similar to the 9% of the OC patients. A head-up position may cause enhanced reduction of hepatic blood flow under pneumoperitoneum [14] . However, abnormal elevation of LFTs was not increased in patients who underwent LC in a head-up position compared to patients in a head-down position in our study (4.4% vs. 5.5%). These data together strongly suggest that pneumoperitoneum and patient position are not responsible for the postoperative abnormal LFTs in patients who underwent laparoscopic surgery.
Transient changes in LFTs are also observed in patients who undergo OG. Previous studies have indicated that division of the ALHA during lymphadenectomy could affect postoperative LFTs [16, 23] . Although there is controversy about whether the ALHA should be preserved during lymphadenectomy, postoperative liver dysfunctions were reported to be transient and resumed within a week. Thus, to ensure en bloc dissection of lymph nodes, we routinely divide the left gastric artery at its root even when the ALHA is recognized during the procedure. Because this policy was equally applied to the LG group and the OG group, the effect of the division of the ALHA should be the same between the two groups. Nevertheless, only in the LG group did half of the patients experience abnormal elevation of LFTs postoperatively. Although the frequency of the ALHA ranged from 12 to 20% in the literature [3, 24, 25] , the ligation of the ALHA alone could not explain the high frequency of liver dysfunction in the LG group.
As Jeong et al. [6] suspected in a recent study, direct liver manipulation is another possible cause for abnormal elevation of LFTs postoperatively [5] [6] [7] . In gastric cancer surgery, liver retraction is essential for performing lymphadenectomy along the lesser curvature, the hepatoduodenal ligament, and the cardiac area. For LG, we introduced a Nathanson liver retractor, which has been used in laparoscopic upper gastrointestinal surgery in Western countries for years. Although this retractor provides a good operative field, elevation of liver enzymes has been reported in some studies of laparoscopic fundoplication or gastric bypass [12, 15] . Among the three previous studies that examined liver functions after LG, only Shinohara et al. [7] used a Nathanson retractor; one study used a snake retractor (Snowden-Pencer TM Diamond-Flex Ò , CareFusion, San Diego, CA, USA) and the other did not mention the liver retraction method. In Shinohara's study and our study in which a Nathanson retractor was used, peak ALT values were 213 and 153, which are much higher than those reported in the other two studies (56 and 89, respectively). These observations suggest that heavier retraction by a Nathanson retractor might cause more severe damage to the liver than the other method. In addition, two studies in which a Nathanson retractor was used required a longer operating time than the other studies (333 and 301 min vs. 270 and 230 min). Because operating time was also significantly longer in patients with elevated LFTs in our study, this factor could also adversely affect the postoperative LFTs. In fact, in the LG group, abnormal elevation of LFTs was observed more frequently in patients who underwent total gastrectomy, which required a longer operating time and heavier retraction compared to patients who underwent distal gastrectomy in our study (60% vs. 45%).
One LG patient in our study experienced a focal liver infarction in the lateral segment. Both injury to the hepatic artery and liver retraction are suspected as causes of liver infarction following gastrectomy [26] . In this patient, the ALHA was recognized and divided during surgery, while the proper hepatic artery was safely preserved. Because the infarction was focal and consistent with the area where a Nathanson retractor was placed, ischemia could also be a result of the intense retraction.
In conclusion, the current study demonstrated that LG results in frequent elevation of LFTs compared with OG. Liver retraction by a Nathanson retractor could be a major cause. Although elevated liver enzymes subsided spontaneously and usually do not affect patient recovery, rare complications such as liver infarction could happen. Therefore, care should be taken to minimize intraoperative liver damage when performing LG by decreasing the duration of liver retraction or using a gentle retraction method. 
